About Uni-Bioscience Pharm Company Limited
Uni-Bioscience Pharm Company LimitedUni-Bio Science is a Hong Kong-listed biopharmaceutical firm focused on regenerative therapeutics for dermatology, orthopaedics, and ophthalmology. It owns three GMP production bases with full R&D, manufacturing, and commercial capabilities, delivering solid financial growth in 2025. Led by Chairman Kingsley Leung, the veteran management team covers finance, R&D, production, and global commercialisation. The Group operates multi-channel domestic sales networks and advances global expansion via overseas licensing and FDA applications of core drugs.






